UCHL1 gain-of-function has been connected to the genesis of various types of tumor, including breast cancer (9), ovarian cancer (10), and lymphoma (11); hence, UCHL1 is regarded as an oncogene (11). This evidence concerns the gene UCHL1 and ovarian carcinoma.